SCHEMBL9856543

SCHEMBL9856543

CNCCC(Cc1c(C)cccc1C)c1ccccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 11/20 0.40
SLC6A2 P23975 6/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
HTR2A P28223 3/20 0.40
HRH1 P35367 3/20 0.40
CHRM1 P11229 2/20 0.40
TSHR P16473 2/20 0.40
ADRA2B P18089 2/20 0.40
HTR2C P28335 2/20 0.40
OPRM1 P35372 2/20 0.40
DRD3 P35462 2/20 0.40
OPRK1 P41145 2/20 0.40
HTR2B P41595 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KCNH2 Q12809 2/20 0.40
KLF10 Q13118 2/20 0.40
HRH3 Q9Y5N1 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9856696 0.81 HTR2A (0.43) SLC6A4SLC6A2CYP3A4CYP2D6HTR2A
SCHEMBL9857049 0.79 SLC6A4 (0.54) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9857056 0.75 HTR2A (0.51) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9856998 0.73 SLC6A4 (0.47) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL9856421 0.67 HTR2A (0.44) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL16545294 0.66 SLC6A4 (0.49) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL6911041 0.66 ALDH1A1 (0.44) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL19399098 0.65 SLC6A4 (0.48) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6
SCHEMBL11079146 0.64 TAAR1 (0.38) SLC6A4SLC6A2CYP3A4CYP2D6HTR2A
SCHEMBL8263713 0.64 HTR2A (0.53) SLC6A4SLC6A2CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996235-A Selectively inhibiting the uptake of serotonin and norepinephrine ELI LILLY AND COMPANY (US) 1991-02-26 US disclosed
EP-0318233-A2 Improvements in or relating to serotonin and norepinephrine uptake inhibitors ELI LILLY AND COMPANY (US) 1989-05-31 EP disclosed